Position in AZN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,671,991
-$23,820,082 QoQ
Shares Held
19,365
-86.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#434
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Phoenix Financial Ltd. holds $174,300,668 across 10 Drug Manufacturers - General names. AZN ranks #8 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
97,019 | $116,367,508 | |
| 2 | ABBV |
AbbVie Inc.
|
47,441 | $11,938,053 | |
| 3 | JNJ |
Johnson & Johnson
|
46,830 | $11,893,414 | |
| 4 | NVO |
Novo Nordisk A S
|
158,343 | $7,590,962 | |
| 5 | MRK |
Merck & Co., Inc.
|
52,551 | $6,752,803 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
114,254 | $6,583,314 | |
| 7 | PFE |
Pfizer Inc
|
253,976 | $6,115,741 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
19,365 | $3,671,991 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,671,991 | 19,365 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $27,492,073 | 139,398 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||